Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $10,200 | 4 | 75.1% |
| Food and Beverage | $3,201 | 80 | 23.6% |
| Education | $188.99 | 2 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $10,728 | 14 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $356.67 | 4 | $0 (2023) |
| Incyte Corporation | $353.71 | 7 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $201.68 | 8 | $0 (2024) |
| Seagen Inc. | $196.49 | 3 | $0 (2023) |
| Gilead Sciences, Inc. | $185.96 | 6 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $184.12 | 5 | $0 (2024) |
| Merck Sharp & Dohme LLC | $160.13 | 3 | $0 (2024) |
| PFIZER INC. | $145.61 | 4 | $0 (2024) |
| Epizyme, Inc., | $121.42 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $754.89 | 24 | AstraZeneca Pharmaceuticals LP ($164.91) |
| 2023 | $1,412 | 38 | Incyte Corporation ($244.10) |
| 2022 | $375.61 | 6 | Incyte Corporation ($109.61) |
| 2021 | $354.71 | 4 | Epizyme, Inc., ($121.42) |
| 2019 | $61.72 | 1 | Janssen Pharmaceuticals, Inc ($61.72) |
| 2018 | $148.56 | 3 | Seattle Genetics, Inc. ($99.00) |
| 2017 | $10,483 | 10 | Janssen Pharmaceuticals, Inc ($10,268) |
All Payment Transactions
86 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | PFIZER INC. | INLYTA (Drug), PADCEV | Food and Beverage | In-kind items and services | $24.06 | General |
| Category: ONCOLOGY | ||||||
| 12/09/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $23.70 | General |
| Category: ONCOLOGY | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: Oncology | ||||||
| 11/16/2024 | ARRAY BIOPHARMA INC | LORBRENA (Drug), BRAFTOVI, MEKTOVI | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: ONCOLOGY | ||||||
| 11/11/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $31.23 | General |
| 10/23/2024 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $26.04 | General |
| Category: Oncology | ||||||
| 10/18/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $31.40 | General |
| 10/09/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $21.29 | General |
| Category: Rare Disease | ||||||
| 09/18/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG | Food and Beverage | In-kind items and services | $34.99 | General |
| Category: ONCOLOGY | ||||||
| 09/16/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $28.88 | General |
| 09/11/2024 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: Oncology | ||||||
| 09/04/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $34.98 | General |
| Category: Hematology | ||||||
| 08/28/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: ONCOLOGY | ||||||
| 08/15/2024 | Lilly USA, LLC | VERZENIO (Drug), RETEVMO, JAYPIRCA | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: Oncology | ||||||
| 07/31/2024 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $23.44 | General |
| Category: Oncology | ||||||
| 07/24/2024 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $23.93 | General |
| Category: Oncology | ||||||
| 06/27/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $29.98 | General |
| Category: Oncology | ||||||
| 06/25/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $106.50 | General |
| Category: Rare Disease | ||||||
| 06/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Stivarga (Drug) | Food and Beverage | In-kind items and services | $27.65 | General |
| Category: Oncology | ||||||
| 06/05/2024 | PFIZER INC. | INLYTA (Drug), XTANDI, TALZENNA | Food and Beverage | In-kind items and services | $22.26 | General |
| Category: ONCOLOGY | ||||||
| 05/09/2024 | PFIZER INC. | INLYTA (Drug), XTANDI, TALZENNA | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: ONCOLOGY | ||||||
| 04/25/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $97.99 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/18/2024 | CSL Behring | HEMGENIX (Biological) | Food and Beverage | In-kind items and services | $24.85 | General |
| Category: Hematology | ||||||
| 02/05/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $31.18 | General |
| 12/26/2023 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $28.01 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 389 | 816 | $131,528 | $55,676 |
| 2022 | 6 | 516 | 910 | $154,996 | $65,936 |
| 2021 | 7 | 555 | 1,103 | $184,788 | $82,082 |
| 2020 | 8 | 566 | 1,088 | $165,681 | $59,174 |
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 194 | 435 | $69,438 | $28,165 | 40.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 62 | 167 | $37,200 | $17,364 | 46.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 116 | 197 | $20,504 | $8,783 | 42.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 17 | 17 | $4,386 | $1,364 | 31.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 223 | 440 | $69,806 | $29,399 | 42.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 88 | 201 | $44,196 | $20,716 | 46.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 121 | 170 | $17,176 | $7,328 | 42.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 29 | 29 | $9,826 | $3,881 | 39.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 30 | 30 | $8,032 | $2,441 | 30.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 25 | 40 | $5,960 | $2,171 | 36.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 230 | 484 | $75,981 | $33,799 | 44.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 95 | 250 | $54,626 | $26,491 | 48.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 137 | 236 | $23,908 | $10,585 | 44.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 31 | 71 | $10,579 | $3,913 | 37.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 32 | 32 | $8,402 | $2,996 | 35.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 17 | 17 | $6,963 | $2,499 | 35.9% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 13 | 13 | $4,329 | $1,800 | 41.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 179 | 448 | $69,888 | $24,965 | 35.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 191 | 344 | $34,400 | $11,555 | 33.6% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 48 | 109 | $23,704 | $8,712 | 36.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 54 | 90 | $13,410 | $4,961 | 37.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 27 | 27 | $10,989 | $4,136 | 37.6% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 37 | 37 | $9,546 | $3,610 | 37.8% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 15 | 15 | $2,250 | $687.94 | 30.6% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 15 | 18 | $1,494 | $547.50 | 36.6% |
About Dr. Jay Walls, MD
Dr. Jay Walls, MD is a Hematology & Oncology healthcare provider based in Greenville, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/16/2005. The National Provider Identifier (NPI) number assigned to this provider is 1821093956.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jay Walls, MD has received a total of $13,590 in payments from pharmaceutical and medical device companies, with $754.89 received in 2024. These payments were reported across 86 transactions from 29 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($10,200).
As a Medicare-enrolled provider, Walls has provided services to 2,026 Medicare beneficiaries, totaling 3,917 services with total Medicare billing of $262,869. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Practice Information
- Specialty Hematology & Oncology
- Location Greenville, SC
- Active Since 06/16/2005
- Last Updated 06/15/2021
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1821093956
Products in Payments
- XARELTO (Drug) $11,057
- ADCETRIS (Biological) $174.53
- KEYTRUDA (Biological) $160.13
- JAKAFI (Drug) $135.36
- TAZVERIK (Drug) $121.42
- ELIQUIS (Drug) $117.51
- MONJUVI (Drug) $109.61
- ANDEXXA (Biological) $106.50
- COSELA (Drug) $83.85
- SCEMBLIX (Drug) $77.33
- XPOVIO (Drug) $70.55
- AYVAKIT (Drug) $69.75
- INLYTA (Drug) $68.82
- VERZENIO (Drug) $62.56
- Enhertu (Drug) $51.71
- Nubeqa (Drug) $48.71
- CALQUENCE (Drug) $39.97
- REBLOZYL (Biological) $34.98
- MONOFERRIC (Drug) $30.93
- Trodelvy (Drug) $30.66
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Greenville
Dr. Suzanne Fanning, D.o, D.O
Hematology & Oncology — Payments: $1.3M
Dr. Joe Stephenson, Md, MD
Hematology & Oncology — Payments: $137,970
Dr. Paul Walker, M.d, M.D
Hematology & Oncology — Payments: $66,454
Dr. Darla Liles, Md, MD
Hematology & Oncology — Payments: $49,052
William Edenfield, Md, MD
Hematology & Oncology — Payments: $31,038
Dr. Raid Aljumaily, M.d, M.D
Hematology & Oncology — Payments: $21,498